What PSA Testing Actually Measures

Prostate-specific antigen is a protein produced by cells of the prostate gland. A small amount circulates in the bloodstream at all times, but when the prostate is enlarged, inflamed, or affected by cancer, levels tend to rise. A PSA test measures the concentration of this protein in a blood sample, typically expressed in nanograms per milliliter (ng/mL).

It is important to understand that PSA is not a cancer marker in the strict sense — it is a prostate marker. Cancer is one of several conditions that can raise levels. This distinction matters because a high result alone does not indicate what is causing the elevation. For a broader look at how screening tools differ from diagnostic tests, see how screening differs from diagnostic testing.

1 in 8

Men diagnosed with prostate cancer in their lifetime

According to the American Cancer Society, prostate cancer is the most common non-skin cancer among American men.

~4.0 ng/mL

Historical PSA threshold used in clinical practice

This figure was once widely used as a cutoff, but current guidelines emphasize individualized interpretation over a fixed number.

70–80%

Of elevated PSA results not caused by cancer

The National Cancer Institute notes that most PSA elevations are attributable to benign conditions such as enlarged prostate or prostatitis.

Interpreting Results: Why Context Is Everything

PSA results are rarely interpreted in isolation. Clinicians consider multiple factors when evaluating what a given number means:

  • Age: PSA naturally increases as the prostate grows with age, so the same level carries different significance at 55 versus 75.
  • PSA velocity: A rapid rise over time — even within a "normal" range — may be more telling than a single snapshot reading.
  • Free vs. total PSA ratio: PSA travels in two forms in the blood. A lower proportion of free PSA relative to total PSA is associated with a higher likelihood of cancer.
  • Prostate size: A larger prostate naturally produces more PSA regardless of cancer. PSA density (level adjusted for prostate volume) adds useful context.

For a plain-language breakdown of what specific PSA numbers may suggest, our detailed guide to PSA result interpretation walks through what different levels can mean.

Before Your PSA Test: A Few Practical Notes

Certain activities can temporarily raise PSA levels and potentially skew results. Ejaculation within 24–48 hours of the test, vigorous cycling, and recent prostate examinations may all cause a short-term increase. Let your doctor know about any recent activities or medications — including some herbal supplements — before your blood draw, so results can be interpreted accurately.

The Limits of PSA Screening and Why the Decision Is Personal

PSA testing is a genuinely useful tool, but it has well-documented limitations that every patient should understand before deciding whether to screen.

False positives are common: many men with elevated PSA do not have cancer, yet may undergo biopsies that carry their own risks, including infection and anxiety. Conversely, false negatives occur — some prostate cancers develop without significantly raising PSA levels.

There is also the issue of overdiagnosis: PSA screening can detect slow-growing cancers that may never cause symptoms or shorten life, yet treatment for those cancers carries real side effects including incontinence and erectile dysfunction. This has led major health bodies, including the U.S. Preventive Services Task Force, to frame screening as a shared decision rather than a blanket recommendation.

Common misconceptions — such as assuming a normal PSA guarantees a healthy prostate — are explored in our companion piece on what older men often get wrong about prostate screening.

Who Should Consider Earlier Screening Conversations

While average-risk men are typically advised to begin discussing PSA testing with their physician around age 50–55, certain groups face higher baseline risk and may benefit from earlier conversations:

  • Black men: According to the American Cancer Society, Black men are more likely to be diagnosed with prostate cancer and at a younger age. Earlier discussion — around age 40–45 — is recommended.
  • Men with a first-degree relative (father or brother) diagnosed with prostate cancer before age 65 also fall into a higher-risk category warranting earlier evaluation.
  • Men with known BRCA2 gene mutations carry an elevated risk and should discuss individualized screening timelines with a specialist.

For a comprehensive overview of prostate anatomy, conditions, and how screening fits into long-term prostate health, see Prostate Health From Diagnosis to Daily Life.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any medical concerns or screening decisions.